Results
Research shows Flemish industry can become climate-neutral
The transformation to climate neutrality is a particularly difficult task, not least because basic industry still relies heavily on fossil resources. Researchers at the Vrije Universiteit Brussel have now shown that there are nevertheless routes to make Flemish industry climate-neutral.
Read more
Launch of LevensEindeApp "LEA"
VUB professor Wim Distelmans supports app to help care providers
Forum Palliative Care and LevensEinde InformatieForum (LEIF), part of the Waardig Levenseinde Expertise Centre in Wemmel, are launching the LevensEindeApp (EndOfLifeApp, LEA) for doctors and care providers.
Read more
Partners
Read more
Top VUB researchers receive prestigious Methusalem funding
The Methusalem programme is one of the most prestigious types of funding in Flanders.
Read more
MOBI lab tour by Joeri Van Mierlo
Visit the Youtube channel of MOBI, the Mobility, Logistics and Automotive Technology Research Centre of the VUB and watch videos about seminars, research pitches and more. Discover the lab during a virtual tour with Joeri Van Mierlo (head of MOBI). Watch here
Read more
Flemish universities join forces for scientific excellence
It's full speed ahead for interuniversity scientific excellence, as Flemish universities are pooling their resources to finance interuniversity research consortia for the first time. They are investing more than €36 million in iBOF funding.
Read more
Brain enzyme caught in the act
Researchers from the lab of Wim Versées (VIB-VUB Center for Structural Biology) in collaboration with the team of Patrik Verstreken (VIB-KU Leuven Center for Brain & Disease Research) presents the three-dimensional structure of an enzyme involved in Parkinson’s disease, epilepsy, Alzheimer's dis...
Read more
Guidelines for (applied) research: Covid-update 2021
Please take note of the amended guidelines for research and applied research and valorisation. From now on research with test subjects on campus is in principle not allowed (unless digital). This applies to research on both adults and children.
Read more
New Chief Business Officer at Precirix
VUB spin-off Precirix, a private, clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, announces the appointment of Dr. Niva Almaula, an experienced business development executive based in New York, as Chief Business Officer. In this role, Dr.
Read more
Upgrade of cryo-EM toolbox for structural biology
VIB introduces an upgrade to its toolbox for structural analysis of biological molecules, leading the way for drug development. These tools help to overcome critical obstacles that limit the resolution of cryo-electron microscopy (cryo-EM) reconstructions.
Read more